Scientific Programme
Tuesday 13 December

  • Tuesday 13 December 2016
  • 08:00
    Interactive computerized radiology workshop
  • Session 7: Prevention and screening
    08:15 - 09:30 hrs.
    • 08:15
      Taiwan: data from the nationwide CRC screening program (10 years experience)

      Chiu Han-Mo, National Taiwan University Hospital, Taiwan
    • 08:40
      Screening uptake and socioeconomic status

      Clasine de Klerk, Academic Medical Centre, the Netherlands
    • 09:05
      Biomarker screening tests for colorectal cancer

      Gerrit Meijer, Netherlands Cancer Institute, the Netherlands
  • Session 8: Genetics
    09:30 - 10:45 hrs.
    • 09:30
      Germline genetic testing form targeted testing to panel testing

      Maurizio Genuardi, University of the Sacred Heart, Italy
    • 09:45
      Genetic risk communication in daily practice

      Jan Oosterwijk, University Medical Centre Groningen, the Netherlands
    • 10:00
      Adding a family history to population CRC screening

      Nicoline Hoogerbrugge, Radboud University Medical Centre, the Netherlands
    • 10:15
      NGS in germline or somatic testing

      Elke Holinski, Medical Genetics Center, Germany
    • 10:30
      Characterization of unclassified MMR gene variants

      Hein te Riele, Netherlands Cancer Institute, the Netherlands
  • 10:45
    Break
  • Session 9: Colorectal cancer and the immune system
    11:15 - 12:30 hrs.
    • 11:15
      Principles of immunotherapy

      Erik Hooijberg, VU university medical cente, the Netherlands
    • 11:45
      Current status and future prospects of immunotherapy in colorectal cancer

      Miriam Koopman, University Medical Center Utrecht, the Netherlands
  • Oral presentations selected abstracts
    12:30 - 13:00 hrs.
    • 12:30
      Biological mesh closure of the pelvic floor after extralevator abdominoperineal resection for rectal cancer: a single blinded, multicentre randomised controlled trial (the BIOPEX-study).

      Lotje Klaver, Academic Medical Center, Amsterdam, the Netherlands
    • 12:40
      Accuracy of colon capsule endoscopy (CCE) in polyp detection of IFOBT positive colorectal cancer screening individuals, compared to optical colonoscopy (OC)

      R. Kroijer, Odense University Hospital, Denmark
    • 12:50
      Organ preservation with chemoradiotherapy and local excision for locally advanced rectal cancer

      Dr. B. Creavin, St Vincents University Hospital, Dublin, Ireland
  • 13:00
    Lunch & Posters
  • Session 10: Rectal cancer surgery
    14:00 - 15:15 hrs.
    • 14:00
      A patient tailored approach to low rectal cancer

      Yves Panis, Hôspital Beaujon Paris, France
    • 14:25
      Is there still an oncological safety issue in laparoscopic rectal cancer surgery?

      Roel Hompes, University of Oxford, United Kingdom
    • 14:50
      Transanal TME as the step forward in minimally invasive rectal cancer surgery

      Jurriaan Tuynman, VU university medical cente, the Netherlands
  • Session 11: Controversy 2
    15:15 - 16:05 hrs.
    • 15:15
      PRO || Wait and see after clinical complete response following chemoradiotherapy for rectal cancer is an acknowledged treatment option

      Geerard Beets, Netherlands Cancer Institute, the Netherlands
    • 15:15
      CON || Wait and see after clinical complete response following chemoradiotherapy for rectal cancer is an acknowledged treatment option

      Rob Glynne-Jones, Mount Vernon Cancer Centre, United Kingdom
    • 15:40
      PRO || Improving complete responders of chemo-radiotherapy, role of systamic therapy

      Garrett Nash, Memorial Sloan Kettering Cancer Centre, United States
    • 15:40
      CON || Improving complete responders of chemo-radiotherapy, role of systamic therapy

      Maria Antonietta Gambacorta, Catholic University of the Sacred Heart, Italy
  • 16:05
    Break
  • Session 12: Interval colorectal cancer: from nomenclature to benchmarking
    16:30 - 17:50 hrs.
    • 16:30
      Interval CRC: What and Why?

      Silvia Sanduleanu, Maastricht University Medical Center, the Netherlands
    • 16:50
      Interval cancer after colonoscopy – data from the Bowel Cancer Screening Program

      Matthew Rutter, NHS Foundation Trust, United Kingdom
    • 17:10
      Interval cancers: Can we avoid them?

      Chiu Han-Mo, National Taiwan University Hospital, Taiwan
    • 17:30
      The molecular secrets of interval cancers

      Beatriz Carvalho, Netherlands Cancer Institute, the Netherlands
  • 18:00
    Closing & drinks